Smith & Nephew Plc
16 July 2007
Timing of Smith & Nephew Second Quarter
and Interim Results
16 July 2007
Smith & Nephew plc will be announcing its second quarter and Interim results
ending 1 July 2007 on Thursday 2 August 2007 at 11am BST/6am Eastern. This will
be followed by a presentation for financial analysts at 1pm BST/8am Eastern,
which can be seen live via webcast on the Smith & Nephew website at
www.smith-nephew.com and available on the site archive shortly afterwards.
About Us
Smith & Nephew (LSE: SN.L; NYSE: SNN) is one of the world's leading medical
device companies, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma
and Clinical Therapies, Endoscopy and Advanced Wound Management. Smith & Nephew
is a global leader in arthroscopy and advanced wound management and is one of
the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself on the strength of its relationships with its surgeon and
healthcare professional customers, with whom its name is synonymous with the
highest standards of performance, innovation and trust. The company has over
8,800 employees and operates in 31 countries around the world, generating sales
of $2.8 billion.
Enquiries:
Smith & Nephew UK
Julie Allen Tel: +44 (0)20 7401 7646
Corporate Affairs co-ordinator
Media
Jon Coles +44 (0) 20 7404 5959
Brunswick - London
Cindy Leggett-Flynn +1 (212) 807 8319
Brunswick - New York
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.